IL-18 is essentially a pro-inflammatory cytokine that activates NF-κB [64], and it has a dual effect in tumor progression: it can activate immune responses and eliminate cancer cells, whereas higher levels of IL-18 promote angiogenesis, metastasis, proliferation and immune escape [65]. Here, NFKB1 is linked to cancer.